FIRMQUARRY / COMPANY INTELLIGENCE
LIFE TECHNOLOGIES CORPORATION
Other · GRAND ISLAND, NY · observed recipient location
COMPANY-SPECIFIC CONTRACT CYCLE / THREE-YEAR BASELINE
Is this company winning more—or less—than usual?
Current 12-month net U.S. obligations compared with the company's own annual average over the preceding three years, not a universal benchmark.
We show a directional signal only when the difference is at least 25% and $250,000, with enough historical coverage. Missing records and irregular procurement cycles limit interpretation.
General information
- Legal name
- LIFE TECHNOLOGIES CORPORATION
- Industry
- Other
- Observed geography
- GRAND ISLAND, NY · Observed recipient location
- First / latest observed
- Oct 21, 2026 — Nov 3, 2026
SUPPORTED COMPANY SIGNALS
Company change signals
Only supported categories appear in the default dossier. Opening from a specific screener keeps that category in focus. Evidence scores are not probabilities.
Company and locations stay distinct
Supported locations & events
Operating locations require independent verification. Recipient addresses and contract work sites are not automatically company facilities.
Expansion
- New federal award+0.0
- New federal award+0.0
- New federal award+0.0
Signal coverage and missing inputs
Multi-source indication scores
Descriptive expansion indication from 3 deduplicated signals across 1 independent source families. Points apply published evidence caps, reliability, strength, confidence, and 180-day time decay; this is not a probability.
As of Oct 28, 2026 · company-change-indication-v2 · medium evidenceIndividual source-backed indicators
No conservatively linked early indicators are available.
One source-backed chronology
Timeline
Business change, facilities, workforce, corporate events, and government activity appear chronologically.
- GovernmentAward increased
PURCHASE ANTI-ANTHRAX TOXIN ANTIBODY, RAXIBACUMAB, IN A SINGLE GLASS VIAL AT THE CONCENTRATION OF 10 MG/ML.
- GovernmentAward announced
PURCHASE ANTI-ANTHRAX TOXIN ANTIBODY, RAXIBACUMAB, IN A SINGLE GLASS VIAL AT THE CONCENTRATION OF 10 MG/ML.
- GovernmentAward announced
LIFE TECHNOLOGIES CORPORATION:1107072 [23-003286]
- GovernmentAward announced
DYNABEADS CD3/CD28 CTS 10ML -- CATALOG # : 40203D
- GovernmentAward increased
DYNABEADS CD3/CD28 CTS 10ML -- CATALOG # : 40203D
- GovernmentAward announced
DYNABEADS DYNABEADS CD3 CD28 CTS.
- GovernmentAward increased
DYNABEADS DYNABEADS CD3 CD28 CTS.
- GovernmentAward announced
BIOWATCH INVENTORY
- GovernmentAward announced
BIOWATCH INVENTORY
- GovernmentAward announced
LIFE TECHNOLOGIES CORPORATION:1107072 [19-014735]
- GovernmentAward increased
LIFE TECHNOLOGIES CORPORATION:1107072 [19-014735]
Disclosed procurement context
Government Business
Money leads this view. Values represent disclosed obligations and procurement amounts—not company revenue.
Global government business
Markets and currencies remain separate; incompatible currencies are never summed.
| Market | Disclosed value | Currency | Latest activity | Processes |
|---|---|---|---|---|
| US | $0 | USD | Sep 25, 2023 | 7 |
Top agencies by net obligations
- 01Department of Health and Human Services7 awards$2M
Top work locations by net obligations
- 01GRAND ISLAND, ERIE, NY6 awards$2M
- 02SILVER SPRING, MONTGOMERY, MD1 awards$17.5K
Latest U.S. awards
Explore the most recent records here, or open the full company archive to filter across all available years.
| Date | Contract | Company | Buyer / agency | Value | Industry | Country / work location | Outlook |
|---|---|---|---|---|---|---|---|
| Sep 25, 2023 | PURCHASE ANTI-ANTHRAX TOXIN ANTIBODY, RAXIBACUMAB, IN A SINGLE GLASS VIAL AT THE CONCENTRATION OF 10 MG/ML. | LIFE TECHNOLOGIES CORPORATION | Department of Health and Human Services | $17.5K | Other | SILVER SPRING · MD | Insufficient history |
| Jan 13, 2023 | LIFE TECHNOLOGIES CORPORATION:1107072 [23-003286] | LIFE TECHNOLOGIES CORPORATION | Department of Health and Human Services | $18.4K | Other | GRAND ISLAND · NY | Insufficient history |
| Nov 15, 2021 | DYNABEADS CD3/CD28 CTS 10ML -- CATALOG # : 40203D | LIFE TECHNOLOGIES CORPORATION | Department of Health and Human Services | $20.7K | Other | GRAND ISLAND · NY | Insufficient history |
| Aug 5, 2021 | DYNABEADS DYNABEADS CD3 CD28 CTS. | LIFE TECHNOLOGIES CORPORATION | Department of Health and Human Services | $10.4K | Other | GRAND ISLAND · NY | Insufficient history |
| Apr 7, 2020 | BIOWATCH INVENTORY | LIFE TECHNOLOGIES CORPORATION | Department of Health and Human Services | $84.5K | Not reported | GRAND ISLAND · NY | Insufficient history |
| Mar 23, 2020 | BIOWATCH INVENTORY | LIFE TECHNOLOGIES CORPORATION | Department of Health and Human Services | $1.8M | Not reported | GRAND ISLAND · NY | Insufficient history |
| Sep 11, 2019 | LIFE TECHNOLOGIES CORPORATION:1107072 [19-014735] | LIFE TECHNOLOGIES CORPORATION | Department of Health and Human Services | $20K | Other | GRAND ISLAND · NY | Insufficient history |
GOVERNMENT BUSINESS / ANNUAL HISTORY
Annual net U.S. obligations
Disclosed federal transaction obligations, including deobligations. Not company revenue or contract ceiling.
Historical awards and modifications are preserved as individual records.
Browse all company contracts ↗